The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 17, 2023

Filed:

Sep. 20, 2021
Applicant:

Precision Biosciences, Inc., Durham, NC (US);

Inventors:

James Jefferson Smith, Morrisville, NC (US);

Janel Lape, Wake Forest, NC (US);

Victor Bartsevich, Durham, NC (US);

Hui Li, Apex, NC (US);

Assignee:

Precision BioSciences, Inc., Durham, NC (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/22 (2006.01); C12N 15/86 (2006.01); C12N 15/85 (2006.01); A61K 47/69 (2017.01); A61K 9/16 (2006.01);
U.S. Cl.
CPC ...
C12N 9/22 (2013.01); A61K 9/1617 (2013.01); A61K 47/6929 (2017.08); C12N 15/86 (2013.01); C12N 2015/8518 (2013.01);
Abstract

The present invention encompasses engineered nucleases which recognize and cleave a recognition sequence within a Hepatitis B virus (HBV) genome. The engineered meganucleases can exhibit at least one optimized characteristic, such as enhanced specificity and/or efficiency of indel formation, when compared to the first-generation meganuclease HBV 11-12x.26. Further, the invention encompasses pharmaceutical compositions comprising engineered meganuclease proteins, nucleic acids encoding engineered meganucleases, and the use of such compositions for treating HBV infections or hepatocellular carcinoma.


Find Patent Forward Citations

Loading…